5 results
antinxp2dm cvid dermatomyositis differential hypogammaglobulinemia immunodeficiency immunology lupus sjogrens syndrome systemic variable vasculitides vasculitis
SLE (Systemic Lupus Erythematosus) Suspect: Clinical evidence of (fatigue, rash, photosensitivity, inflammatory arthritis, weight loss, and fever) and
Classification: ... fibromyalgia) • Infections ... Kidney disease common ... Chronic B-cell activation ... #Diagnosis #Rheumatology
Common Variable Immunodeficiency (CVID) What? CVID: Immunodeficiency disorder with hypogammaglobulinemia -> increased infection risk secondary to impaired B-cell
to 8 years Clinical ... lung disease (GLILD ... DDX - Other causes ... hypogammaglobulinemia #immunology #hematology ... #diagnosis #management
Sjogren's Syndrome Overview Epidemiology: • F > M: 9:1 • 5-6th Decades (can be any age) Autoimmune exocrinopathy multisystemic disease
overlaps with RA, SLE ... ab • RF • Antinuclear ... MALT Lymphoma • Lung ... Sjogrens #Syndrome #Rheumatology ... #Diagnosis #Management
Vasculitis and Vasculitides - Differential Diagnosis Framework When to Consider Vasculitis: • Purpura, ischemic skin lesions •
often causes arthritis ... LFT • ESR • ANA ... SLE) • Urinalysis ... #rheumatology # ... classification
Anti-NXP-2 Dermatomyositis What? DM with generalized subcutaneous edema Pts have more myalgias, more severe weakness, and an increased prevalence
• Antibodies targeting ... papules Clinical ... #diagnosis #management ... #rheumatology # ... dermatology
No results found for "Bursitis diagnosis sle pulmonary lung disease ct interstitial rheumatology clinical hematology erythematosus dermatology ana causes infections classification antinxp2 antibodies activation palpable antinuclear management common"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Bursitis #diagnosis #sle #pulmonary #lung #disease #ct #interstitial #rheumatology #clinical #hematology #erythematosus #dermatology #ana #causes #infections #classification #antinxp2 #antibodies #activation #palpable #antinuclear #management #common